Metabolic Aspirin Effectiveness and its Influence on Cardiovascular Risk Jeffrey Boone, M.D. The Microbiome and Cardiovascular Disease Thomas Sult, MD Pharmacological Principles of Treating Type 1 Diabetes Mellitus Blair Geho, MD, PhD Diabesity and Insulin Resistance from a Functional Medicine Perspective Filomena Trindade, MD, MPH The Human Microbiome in Health and Disease Robert Rountree, MD Tame the Flames of PCOS: A Unique Integrative Approach Felice Gersh, MD Why We Get Fat?: An Alternative Hypothesis of Obesity Gary Taubes « Page 1 » CME Webcasts Identifying Subclinical Cardiovascular Disease Effect of Dietary Lipids on the Gut Microbiome: What Do We Know? Metabolic Basis of CVD Prevention News You Can Use Can Circulating Vitamin D Levels Provide Useful Information about Coronary Artery Disease status? More Data on the Value of Detecting Microalbuminuria when Assessing Cardiovascular Risk Nonobstructive CAD, Women, and Prevention of Cardiovascular Events Are Low Levels of Vitamin D in Youth a Cardiovascular Risk Factor? Is Now the Time to Target Both LDL and Inflammation?